According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are โฌ0.37 Billion. In 2023 the company made an earning of -โฌ0.88 Billion a decrease over its 2022 earnings that were of โฌ0.23 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | โฌ65.21 M | -107.43% |
2023 | -โฌ0.88 Billion | -475.59% |
2022 | โฌ0.23 B | 25.8% |
2021 | โฌ0.18 B | 84.32% |
2020 | โฌ0.10 B | 84.69% |
2019 | โฌ54.58 M | -125.13% |
2018 | -โฌ0.22 Billion | 100.62% |
2017 | -โฌ0.11 Billion | 43.12% |
2016 | -โฌ75.67 Million | -42.73% |
2015 | -โฌ0.14 Billion | -24.76% |
2014 | -โฌ0.18 Billion | -30.49% |
2013 | -โฌ0.26 Billion | 275.65% |
2012 | -โฌ67.25 Million | 11.56% |
2011 | -โฌ60.29 Million | 9.38% |
2010 | -โฌ55.12 Million | -15.21% |
2009 | -โฌ65.01 Million |